Daily FNArena News

PanAust delivered a solid September quarter production report and with a strong balance sheet and growth options in development, Buy ratings continue to dominate.

A glance through the latest expert views and predictions about commodities with updates on oil and the bulks, support for platinum and updated base metal forecasts.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Global equity markets have largely stalled following a strong run-up. As we move through end-year uncertainty, analysts discuss their views for equities in 2013.

AMP’s funds flow has improved but other issues remain to drag on broker ratings.

Uranium prices continued to drift despite ever increasing talk of eventual demand.

A wrap of the day’s activity on the Australian stock market.

ResMed delivered a solid quarterly seeing brokers lift earnings forecasts, but ratings remain split between Buy and Hold given concerns with respect to competitive bidding.

The sharp rebound in iron ore prices has been as surprising as the earlier crunch but is the correction now set to run out of steam?

Update on share prices and consensus price targets. Banks share prices look expensive but is this assessment still correct?

AGM commentary from Amcor has reiterated previous earnings guidance for FY13 and on the news broker ratings for the stock remain weighted to the Buy side.